A Role of Oxidative Stress-Generated Eicosanoid in the Progression of Arteriosclerosis in Type 2 Diabetes Mellitus Model Rats

Diabetes mellitus (DM) is a well-established risk factor of cardiovascular diseases. We investigated the mechanism of the progression of arteriosclerosis in DM, focusing on the role of oxidative stress and insulin resistance in vivo. Male Otsuka Long-Evans Tokushima Fatty (OLETF) rats, an experiment...

Full description

Saved in:
Bibliographic Details
Published inHypertension Research Vol. 25; no. 1; pp. 91 - 98
Main Authors SHINOMIYA, Kaori, FUKUNAGA, Megumu, KIYOMOTO, Hideyasu, MIZUSHIGE, Katsufumi, TSUJI, Teppei, NOMA, Takahisa, OHMORI, Koji, KOHNO, Masakazu, SENDA, Shoichi
Format Journal Article
LanguageEnglish
Published England The Japanese Society of Hypertension 2002
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Diabetes mellitus (DM) is a well-established risk factor of cardiovascular diseases. We investigated the mechanism of the progression of arteriosclerosis in DM, focusing on the role of oxidative stress and insulin resistance in vivo. Male Otsuka Long-Evans Tokushima Fatty (OLETF) rats, an experimental model of type 2 DM, were assigned to 3 groups, based on supplementation with vitamin E (VE) or troglitazone (TR), a VE-derived agent which improves insulin-resistance. At 36 weeks, plasma and aortic tissue 8-iso-PGF2α contents, a vascular proliferating eicosanoid produced in vivo by oxidative stress, were measured by EIA. TGF-β1 and TGF-β1 receptor II were immunohistochemically analyzed. Histopathologically, medial area and the nuclear number of smooth muscle cells of the aorta were measured. The tissue 8-iso-PGF2α content (pg⁄g tissue) was significantly decreased by either VE or TR in the aorta (untreated-OLETF, 15,332±3,254 vs. TR-treated-OLETF, 7,092±1,992 or VE-treated-OLETF, 5,394±836, both p<0.01), but that in plasma decreased by only VE. VE and TR improved the increased the level of the actual medial area and the number of smooth muscle cells. The expression of TGF-β1 was reduced, but TGF-β1 receptor II was not. 8-iso-PGF2α may play an important role in the progression of arteriosclerosis. Antioxidant treatment may promise significant clinical benefits in the early diabetic stage. (Hypertens Res 2002; 25: 91-98)
AbstractList Diabetes mellitus (DM) is a well-established risk factor of cardiovascular diseases. We investigated the mechanism of the progression of arteriosclerosis in DM, focusing on the role of oxidative stress and insulin resistance in vivo. Male Otsuka Long-Evans Tokushima Fatty (OLETF) rats, an experimental model of type 2 DM, were assigned to 3 groups, based on supplementation with vitamin E (VE) or troglitazone (TR), a VE-derived agent which improves insulin-resistance. At 36 weeks, plasma and aortic tissue 8-iso-PGF2alpha contents, a vascular proliferating eicosanoid produced in vivo by oxidative stress, were measured by EIA. TGF-beta1 and TGF-beta1 receptor II were immunohistochemically analyzed. Histopathologically, medial area and the nuclear number of smooth muscle cells of the aorta were measured. The tissue 8-iso-PGF2alpha content (pg/g tissue) was significantly decreased by either VE or TR in the aorta (untreated-OLETF, 15,332+/-3,254 vs. TR-treated-OLETF, 7,092+/-1,992 or VE-treated-OLETF, 5,394+/-836, both p<0.01), but that in plasma decreased by only VE. VE and TR improved the increased the level of the actual medial area and the number of smooth muscle cells. The expression of TGF-beta1 was reduced, but TGF-beta1 receptor II was not. 8-iso-PGF2alpha may play an important role in the progression of arteriosclerosis. Antioxidant treatment may promise significant clinical benefits in the early diabetic stage.
Diabetes mellitus (DM) is a well-established risk factor of cardiovascular diseases. We investigated the mechanism of the progression of arteriosclerosis in DM, focusing on the role of oxidative stress and insulin resistance in vivo. Male Otsuka Long-Evans Tokushima Fatty (OLETF) rats, an experimental model of type 2 DM, were assigned to 3 groups, based on supplementation with vitamin E (VE) or troglitazone (TR), a VE-derived agent which improves insulin-resistance. At 36 weeks, plasma and aortic tissue 8-iso-PGF2α contents, a vascular proliferating eicosanoid produced in vivo by oxidative stress, were measured by EIA. TGF-β1 and TGF-β1 receptor II were immunohistochemically analyzed. Histopathologically, medial area and the nuclear number of smooth muscle cells of the aorta were measured. The tissue 8-iso-PGF2α content (pg⁄g tissue) was significantly decreased by either VE or TR in the aorta (untreated-OLETF, 15,332±3,254 vs. TR-treated-OLETF, 7,092±1,992 or VE-treated-OLETF, 5,394±836, both p<0.01), but that in plasma decreased by only VE. VE and TR improved the increased the level of the actual medial area and the number of smooth muscle cells. The expression of TGF-β1 was reduced, but TGF-β1 receptor II was not. 8-iso-PGF2α may play an important role in the progression of arteriosclerosis. Antioxidant treatment may promise significant clinical benefits in the early diabetic stage. (Hypertens Res 2002; 25: 91-98)
Author FUKUNAGA, Megumu
TSUJI, Teppei
OHMORI, Koji
NOMA, Takahisa
SHINOMIYA, Kaori
KIYOMOTO, Hideyasu
SENDA, Shoichi
MIZUSHIGE, Katsufumi
KOHNO, Masakazu
Author_xml – sequence: 1
  fullname: SHINOMIYA, Kaori
  organization: Second Department of Internal Medicine, Kagawa Medical University
– sequence: 2
  fullname: FUKUNAGA, Megumu
  organization: Department of Integrated Medicine, Kagawa Medical University
– sequence: 3
  fullname: KIYOMOTO, Hideyasu
  organization: Second Department of Internal Medicine, Kagawa Medical University
– sequence: 4
  fullname: MIZUSHIGE, Katsufumi
  organization: Second Department of Internal Medicine, Kagawa Medical University
– sequence: 5
  fullname: TSUJI, Teppei
  organization: Second Department of Internal Medicine, Kagawa Medical University
– sequence: 6
  fullname: NOMA, Takahisa
  organization: Second Department of Internal Medicine, Kagawa Medical University
– sequence: 7
  fullname: OHMORI, Koji
  organization: Second Department of Internal Medicine, Kagawa Medical University
– sequence: 8
  fullname: KOHNO, Masakazu
  organization: Second Department of Internal Medicine, Kagawa Medical University
– sequence: 9
  fullname: SENDA, Shoichi
  organization: Department of Integrated Medicine, Kagawa Medical University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/11924732$$D View this record in MEDLINE/PubMed
BookMark eNpN0M1PHCEYBnBibOpqe_PccOrJ2c4LzAfHjVo1sbGx9kwY5sXFzA5bYE334P8um9laL0DCjwd4jsnh6Eck5BTKOTAJ35bbdcA4Z9VcwgGZARdtIRiIQzIrJdSFrHl9RI5jfCpL1lYSPpIjAMlEw9mMvCzovR-Qekvv_rpeJ_eM9FfKibG4whGDTtjTS2d81KN3PXUjTUukP4N_3CHnx93ZRUgYnI9mwOCjizv2sF0jZfTC6Q4TRvoDh8GlTV74Hgd6r1P8RD5YPUT8vJ9PyO_vlw_n18Xt3dXN-eK2MFUjUlG3RjBrBWu5tdizzjTGWC163XadrluAppKs6aU2tWWs40JbFE0tgFWtsJqfkK9T7jr4PxuMSa1cNPk9ekS_iaqBquVcNhmeTdDkb8SAVq2DW-mwVVCqXd1qqluxSknI_Ms-d9OtsP-P9_1msJjAU0z6Ed-ADsnlrt6lwTTkG_7tmaUOCkf-CkNJmGg
CitedBy_id crossref_primary_10_1016_j_plefa_2008_03_001
crossref_primary_10_1002_cbf_1016
crossref_primary_10_1517_14712598_7_3_293
crossref_primary_10_1016_j_jtos_2020_06_004
crossref_primary_10_1371_journal_pone_0106003
crossref_primary_10_1196_annals_1331_020
crossref_primary_10_1016_j_biopha_2004_09_012
crossref_primary_10_1007_s00018_012_0982_9
crossref_primary_10_1291_hypres_26_493
crossref_primary_10_1291_hypres_26_691
crossref_primary_10_1016_j_mam_2007_05_002
crossref_primary_10_1016_j_mam_2007_07_001
crossref_primary_10_3177_jnsv_53_48
crossref_primary_10_1097_01_hjh_0000226199_51805_88
crossref_primary_10_1016_j_chembiol_2018_11_015
crossref_primary_10_1002_ptr_7454
crossref_primary_10_1291_hypres_31_783
crossref_primary_10_1093_cvr_cvs301
crossref_primary_10_1097_00005344_200306000_00014
crossref_primary_10_1161_01_HYP_0000163462_98381_7f
crossref_primary_10_1016_j_jacc_2004_04_050
Cites_doi 10.2337/diacare.19.3.257
10.1291/hypres.23.601
10.1016/S1359-6101(99)00034-9
10.1016/S0005-2760(96)00162-2
10.1016/S0076-6879(99)00106-8
10.1001/archinte.1997.00440230053007
10.1291/hypres.24.251
10.1161/01.CIR.95.11.2492
10.1074/jbc.271.25.14916
10.1055/s-0029-1211323
10.1291/hypres.22.67
10.1291/hypres.23.91
10.1161/01.CIR.94.1.19
10.2337/diabetes.40.4.405
10.1161/01.CIR.96.10.3314
10.1073/pnas.87.23.9383
10.2337/diabetes.48.12.2398
10.1172/JCI117107
10.1161/01.CIR.101.8.899
10.1016/S0140-6736(96)90866-1
10.1161/01.HYP.29.3.728
10.7326/0003-4819-123-11-199512010-00009
10.1161/01.RES.70.3.593
10.1172/JCI110852
10.1172/JCI118991
10.1056/NEJM199505043321804
10.1097/00005344-200001000-00020
10.1016/0735-1097(95)00126-K
10.1046/j.1365-2796.2000.00654.x
10.1172/JCI115826
10.1111/j.1523-1755.2000.00368.x
10.1152/ajpheart.1996.271.1.H159
10.1016/S0140-6736(98)07019-6
10.1152/ajpcell.1993.264.6.C1619
10.1056/NEJM200005043421807
ContentType Journal Article
Copyright 2002 by the Japanese Society of Hypertension
Copyright_xml – notice: 2002 by the Japanese Society of Hypertension
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1291/hypres.25.91
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1348-4214
EndPage 98
ExternalDocumentID 10_1291_hypres_25_91
11924732
article_hypres_25_1_25_1_91_article_char_en
Genre Journal Article
GroupedDBID ---
-Q-
.55
0R~
29I
2WC
39C
3V.
4.4
406
53G
5GY
70F
7X7
88E
8FI
8FJ
AADWK
AANZL
AAPBV
AATNV
AAUGY
AAWBL
AAYFA
AAYJO
AAZLF
ABAWZ
ABLJU
ABUWG
ACBMV
ACBRV
ACBYP
ACGFO
ACGFS
ACIGE
ACKTT
ACMJI
ACRQY
ACTTH
ACVWB
ADBBV
ADHDB
ADMDM
ADQMX
ADYYL
AEDAW
AEFTE
AEJRE
AENEX
AESKC
AEVLU
AEXYK
AFKRA
AFSHS
AGAYW
AGEZK
AGGBP
AGHAI
AHMBA
AHSBF
AILAN
AJCLW
AJDOV
AJRNO
ALFFA
ALMA_UNASSIGNED_HOLDINGS
AMRJV
AMYLF
AXYYD
BAWUL
BENPR
BKKNO
BPHCQ
BVXVI
CS3
DIK
DNIVK
DU5
E3Z
EBLON
EBS
EE.
EIOEI
EJD
EMB
EMOBN
F5P
FDQFY
FERAY
FIZPM
FSGXE
FYUFA
GX1
HZ~
IWAJR
JSF
JSH
JSO
JZLTJ
KQ8
M1P
NAO
NQJWS
NXXTH
NYICJ
O9-
OK1
P2P
PQEST
PQQKQ
PQUKI
PROAC
PSQYO
RJT
RNT
RNTTT
RZJ
SNX
SNYQT
SOHCF
SRMVM
SV3
SWTZT
TAOOD
TBHMF
TDRGL
TKC
TR2
TSG
UKHRP
W2D
X7M
XSB
AACDK
AASML
ABAKF
ABJNI
ABZZP
ACAOD
ACZOJ
AEFQL
AEMSY
AFBBN
AGQEE
AIGIU
ALIPV
CCPQU
CGR
CUY
CVF
DPUIP
ECM
EIF
FIGPU
HMCUK
LGEZI
LOTEE
NADUK
NPM
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c574t-68c42ff4283ffed2bc7ccfa4da8bba681175927d9ac6f22b34afe476412584fa3
ISSN 0916-9636
IngestDate Fri Aug 16 23:11:33 EDT 2024
Fri Aug 23 01:11:49 EDT 2024
Sat Sep 28 07:36:10 EDT 2024
Thu Aug 17 20:29:32 EDT 2023
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c574t-68c42ff4283ffed2bc7ccfa4da8bba681175927d9ac6f22b34afe476412584fa3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.jstage.jst.go.jp/article/hypres/25/1/25_1_91/_article/-char/en
PMID 11924732
PQID 71583397
PQPubID 23479
PageCount 8
ParticipantIDs proquest_miscellaneous_71583397
crossref_primary_10_1291_hypres_25_91
pubmed_primary_11924732
jstage_primary_article_hypres_25_1_25_1_91_article_char_en
PublicationCentury 2000
PublicationDate 2002
2002-Jan
2002-00-00
20020101
PublicationDateYYYYMMDD 2002-01-01
PublicationDate_xml – year: 2002
  text: 2002
PublicationDecade 2000
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Hypertension Research
PublicationTitleAlternate Hypertension Research
PublicationYear 2002
Publisher The Japanese Society of Hypertension
Publisher_xml – name: The Japanese Society of Hypertension
References 30. Morrow JD, Roberts LJ II: Mass spectrometric quantification of F2-isoprostanes in biological fluids and tissues as a measure of oxidant stress. Methods Enzymol 1990; 300: 3-12.
32. Mizushige K, Yao L, Noma T, et al: Alteration in left ventricular diastolic filling and accumulation of myocardial collagen at insulin-resistant prediabetic stage of a Type II diabetic rat model. Circulation 2000; 101:899-907.
33. Kaneto H, Kajimoto Y, Miyagawa J, et al: Beneficial effects of antioxidants in diabetes: possible protection of pancreatic β-cells against glucose toxicity. Diabetes 1999; 48: 2398-2406.
31. Mizushige K, Noma T, Yao L, et al: Effects of troglitazone on collagen accumulation and distensibility of aortic wall in prestage of non-insulin dependent diabetes mellitus of Otsuka Long-Evans Tokushima Fatty rats. J Cardiovasc Pharmacol 2000; 35: 150-155.
8. Giuglliano D, Ceriello A, Paolisso G: Oxidative stress and diabetic vascular complications. Diabetes Care 1996; 19: 257-267.
19. Lynch SM, Morrow JD, Roberts LJ II, Frei B: Formation of noncyclooxygenase-derived prostanoids (F2-isoprostanes) in plasma and low density lipoprotein exposed to oxidative stress in vitro. J Clin Invest 1994; 93: 998-1004.
12. Joki N, Kaname S, Hirakata M, et al: Tyrosine-kinase dependent TGF-β and extracellular matrix expression by mechanical stretch in vascular smooth muscle cells. Hypertens Res 2000; 23: 91-99.
14. Blobe GC, Schiemann WP, Lodish HF: Role of transforming growth factor beta in human disease. N Engl J Med 2000; 342:1350-1358.
39. Natarajan R, Lanting L, Gonzales N, Nadler J: Formation of an F2 -isoprostane in vascular smooth muscle cells by elevated glucose and growth factors. Am J Physiol 1996; 271: H159-H165.
20. Takahashi K, Nammour TM, Fukunaga M, et al: Glomerular actions of a free radical-generated novel prostaglandin, 8-epi-prostaglandin F2α, in the rat: evidence for interaction with thromboxane A2 receptors. J Clin Invest 1992; 90: 136-141.
37. Kyaw M, Yoshizumi M, Tsuchiya K, Kirima K, Tamaki T: Antioxidants inhibit JNK and p38 MAPK activation but not ERK 1⁄2 acrivation by angiotensin II in rat aortic smooth muscle cells. Hypertens Res 2001; 24: 251-261.
2. Malmberg K, Ryden L, Efendic S, et al: Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol 1995; 26: 57-65.
28. Jha P, Flasher M, Lonn E, Farkouch M, Yusuf S: Antioxidant vitamins and cardiovascular disease. Ann Intern Med 1995; 123: 860-872.
38. Montero A, Munger KA, Khan RZ, et al: F2-isoprostanes mediate high glucose-induced TGF-β synthesis and glomerular proteinuria in experimental type I diabetes. Kidney Int 2001; 58: 1963-1972.
15. McCaffrey TA : TGF-betas and TGF-beta receptors in atherosclerosis. Cytokine Growth Factor Rev 2000; 11: 103-114.
9. Van Dam PS, Van Asbeck BS, Erkelens BW, Marx JJM, Gispen W-H, Bravenboer B: The role of oxidative stress in neuropathy and other diabetic complications. Diabetes 1991; 40: 405-412.
22. Pratico D, Smyth EM, Violi F, FitzGerald GA: Local amplification of platelet function by 8-epi-prostaglandin F2α is not mediated by thromboxane receptor isoforms. J Biol Chem 1996; 27: 14916-14924.
17. Roberts LJ II, Morrow JD: The generation and actions of Isoprostanes. Biochim Biophys Acta 1997; 1345: 121-135.
34. King GL, Buzney SM, Kahn CR, Hetu N: Differential responsiveness to insulin of endothelial support cells from micro- and macrovessels. J Clin Invest 1983; 71: 974-979.
5. Brownlee M: Advanced protein glycosylation in diabetes and aging. Annu Rev Med 1994; 154: 2473-2479.
36. Rao GN, Berk BC: Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression. Circ Res 1992; 70: 593-599.
7. Baynes JW: Role of oxidative stress in development of complications in diabetes. Diabetes 1991; 40: 405-412.
13. Pfeiffer A, Schatz H: Diabetic microvascular complications and growth factors. Exp Clin Endocrinol Diabetes 1995; 103: 7-14.
1. Abraira C, Colwell J, Nuttall F, et al: Cardiovascular events and correlates in the Veterans Affairs Diabetes Feasibility Trial: Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes. Arch Intern Med 1997; 157: 181-188.
3. Prospective Diabetes Study Group UK: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853.
35. Law RE, Meehan WP, Xi XP, et al: Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia. J Clin Invest 1996; 98: 1897-1905.
27. Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ: Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge heart antioxidant study (CHAOS). Lancet 1996; 347: 781-786.
16. Ozer NK, Boscoboinik D, Azzi A: New roles of low density lipoproteins and vitamin E in the pathogenesis of atherosclerosis. Biochem Mol Biol Int 1995; 35: 117-124.
26. Reilly M, Delanty N, Roy L, O’Callaghan P, Crean P, FitzGerald GA: Increased formation of the isoprostanes IPF2alpha-I and 8-epi-prostaglandin F2alpha in acute coronary angioplasty: evidence for oxidant stress during coronary reperfusion in humans. Circulation 1997; 96: 3314-3320.
25. Delanty N, Reilly M, Lawson JA, et al: 8-epi PGF2 alpha generation during coronary reperfusion: a potential quantitative marker of oxidant stress in vivo. Circulation 1997; 95: 2492-2499.
4. Katayama S, Inaba M, Motita T, Awata T, Shimamoto K, Kikkawa R: Blood pressure control in Japanese hypertensives with or without type 2 diabetes mellitus. Hypertens Res 2000; 23: 601-605.
18. Morrow JD, Hill KE, Burk RF, Nammour TM, Badr KF, Roberts LJ II: A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxigenase free radical-catalyzed mechanism. Proc Natl Acad Sci USA 1990; 87: 9383-9387.
10. Libby P: Changing concepts of atherogenesis. J Intern Med 2000; 247: 349-358.
29. Yagi K, Kim S, Wanibuchi H, Yamashita T, Yamamura Y, Iwao H: Characteristic of diabetes, blood pressure, and cardiac and renal complications in Otsuka Long-Evans Tokushima Fatty rats. Hypertention 1997; 29:728-735.
6. Vlassara H: Recent progress in advanced glycation end products and diabetic complications. Diabetes 1997; 46 (Suppl 2): S19-S25.
21. Fukunaga M, Makita N, Roberts LJ II, Morrow JD, Takahashi K, Badr KF: Evidence for the existence of F2-isoprostane receptors on rat vascular smooth muscle cells. Am J Physiol 1993; 264: C1619-C1624.
23. Morrow JD, Frei B, Longmire AW, et al: Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers: smoking as a cause of oxidative damage. N Engl J Med 1995; 332: 1198-1203.
24. Reilly M, Delanty N, Lawson JA, FitzGerald GA: Modulation of oxidant stress in vivo in chronic cigarette smokers. Circulation 1996; 94: 19-25.
11. Horiuchi M, Hamai M, Cui T-X, Iwai M, Minokoshi Y: Cross talk between angiotensin II type 1 and type 2 receptors; cellular mechanism of angiotensin type 2 receptor-mediated cell growth inhibition. Hypertens Res 1999; 22: 67-74.
22
(6) 1997; 46 (Suppl 2)
26
27
28
29
(24) 1997; 95
(31) 2000; 101
30
10
32
11
33
12
34
13
35
14
36
15
(23) 1996; 94
37
16
38
17
18
19
(3) 1998; 352
1
2
(25) 1997; 96
4
5
7
8
9
20
21
References_xml – ident: 7
  doi: 10.2337/diacare.19.3.257
– ident: 4
  doi: 10.1291/hypres.23.601
– ident: 14
  doi: 10.1016/S1359-6101(99)00034-9
– ident: 16
  doi: 10.1016/S0005-2760(96)00162-2
– ident: 29
  doi: 10.1016/S0076-6879(99)00106-8
– ident: 1
  doi: 10.1001/archinte.1997.00440230053007
– ident: 36
  doi: 10.1291/hypres.24.251
– volume: 95
  start-page: 2492
  issn: 0009-7322
  year: 1997
  ident: 24
  publication-title: Circulation
  doi: 10.1161/01.CIR.95.11.2492
– ident: 21
  doi: 10.1074/jbc.271.25.14916
– ident: 12
  doi: 10.1055/s-0029-1211323
– ident: 10
  doi: 10.1291/hypres.22.67
– ident: 11
  doi: 10.1291/hypres.23.91
– volume: 94
  start-page: 19
  issn: 0009-7322
  year: 1996
  ident: 23
  publication-title: Circulation
  doi: 10.1161/01.CIR.94.1.19
– volume: 46 (Suppl 2)
  start-page: S19
  issn: 0012-1797
  year: 1997
  ident: 6
  publication-title: Diabetes
– ident: 8
  doi: 10.2337/diabetes.40.4.405
– volume: 96
  start-page: 3314
  issn: 0009-7322
  year: 1997
  ident: 25
  publication-title: Circulation
  doi: 10.1161/01.CIR.96.10.3314
– ident: 17
  doi: 10.1073/pnas.87.23.9383
– ident: 32
  doi: 10.2337/diabetes.48.12.2398
– ident: 5
– ident: 18
  doi: 10.1172/JCI117107
– volume: 101
  start-page: 899
  issn: 0009-7322
  year: 2000
  ident: 31
  publication-title: Circulation
  doi: 10.1161/01.CIR.101.8.899
– ident: 26
  doi: 10.1016/S0140-6736(96)90866-1
– ident: 28
  doi: 10.1161/01.HYP.29.3.728
– ident: 27
  doi: 10.7326/0003-4819-123-11-199512010-00009
– ident: 15
– ident: 35
  doi: 10.1161/01.RES.70.3.593
– ident: 33
  doi: 10.1172/JCI110852
– ident: 34
  doi: 10.1172/JCI118991
– ident: 22
  doi: 10.1056/NEJM199505043321804
– ident: 30
  doi: 10.1097/00005344-200001000-00020
– ident: 2
  doi: 10.1016/0735-1097(95)00126-K
– ident: 9
  doi: 10.1046/j.1365-2796.2000.00654.x
– ident: 19
  doi: 10.1172/JCI115826
– ident: 37
  doi: 10.1111/j.1523-1755.2000.00368.x
– ident: 38
  doi: 10.1152/ajpheart.1996.271.1.H159
– volume: 352
  start-page: 837
  issn: 0140-6736
  year: 1998
  ident: 3
  publication-title: The Lancet
  doi: 10.1016/S0140-6736(98)07019-6
– ident: 20
  doi: 10.1152/ajpcell.1993.264.6.C1619
– ident: 13
  doi: 10.1056/NEJM200005043421807
SSID ssj0028591
Score 1.7792326
Snippet Diabetes mellitus (DM) is a well-established risk factor of cardiovascular diseases. We investigated the mechanism of the progression of arteriosclerosis in...
SourceID proquest
crossref
pubmed
jstage
SourceType Aggregation Database
Index Database
Publisher
StartPage 91
SubjectTerms Animals
Aorta - pathology
arteriosclerosis
Arteriosclerosis - pathology
Arteriosclerosis - physiopathology
Blood Glucose - analysis
diabetes mellitus
Diabetes Mellitus, Type 2
Diabetic Angiopathies - pathology
Diabetic Angiopathies - physiopathology
Dinoprost - analogs & derivatives
Disease Progression
Eicosanoids - physiology
F2-Isoprostanes - blood
insulin-resistance
isoprostanes
Lipids - blood
Male
oxidative stress
Oxidative Stress - physiology
Rats
Rats, Inbred OLETF
Rats, Long-Evans
Receptors, Transforming Growth Factor beta - metabolism
Transforming Growth Factor beta - metabolism
Transforming Growth Factor beta1
Title A Role of Oxidative Stress-Generated Eicosanoid in the Progression of Arteriosclerosis in Type 2 Diabetes Mellitus Model Rats
URI https://www.jstage.jst.go.jp/article/hypres/25/1/25_1_91/_article/-char/en
https://www.ncbi.nlm.nih.gov/pubmed/11924732
https://search.proquest.com/docview/71583397
Volume 25
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Hypertension Research, 2002, Vol.25(1), pp.91-98
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9NAEF6FgjiBeBOee4BT5YDXGz-4RTQ0oXKDSiK1XKy1vdu6ojaKY4ki8Tf5Pczs2o5TQKJwsaJ4_Yjny7z8zQwhL0QcgFFQCQQ5PrfAQgSgBwHLLk9tz8E3M5o8Hu67kwV_fzg87PV-dFhL1SoeJN9-W1fyL1KF70CuWCV7Ccm2J4Uv4DPIF7YgYdj-lYxH2wc1OXD2NUtNC--PuvjDMu2k0Z0cg6xLkRdZ2nAaPyAny_Tj0I4osjqzooSTg8nMNEF2bjKzO01mNsS-nauq1LPTPm8fCNMAqnFrJ7B8qbnwRd6S-drkzWSKsxKPRoa9USyzFjSLvcX-aFfvCOVxdVa1-n96NAtn85m2jFkqz0XZ7gunnxZwzt1xzQYpK1WdZRvpi3WYq0vfwCHAQZstRRVfXnTuuJuutF0LlEXdNtsoaweTocwUoTba3JRRb6DWqGYzFKw28mby9S_mgwVoPk7OkYM8YMNBc8xGQ-5a3JFZFrFhZJtNYEfNPiyZA4ReIVcZKECkmu5M99pEAPYM1D0g699UF2TA1V91r73hKl07hWjhWP45ENIO0fwWuVlHMnRk7uU26cn8Drke1lyNu-T7iCI6aaFoi056EZ10jU6a5RTQSTvoxGMvohOXITopow06aYNOqtFJEZ33yOLdeP52YtXDPqxk6PGV5foJZ0ph_z-lZMrixEsSJXgq_DgWLtZDDwPmpYFIXMVY7HChJPdcDh66z5Vw7pOtvMjlQ0IVk0GsYgmRg8-ZcHyRsOS1lG7AXI8z3icvm-cafTE9XSKMheH5d4Qa2H3yxjz0dtUlRN8nzxtBRaCx8TUcQL2oysizsdIx8PrkgZHf-iYwG-I57NH_XPgxuYH_Mz21SKcKn5Ct1bKST8F5XsXPNBJ_AkkI0OM
link.rule.ids 315,783,787,4031,27935,27936,27937
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+Role+of+Oxidative+Stress-Generated+Eicosanoid+in+the+Progression+of+Arteriosclerosis+in+Type+2+Diabetes+Mellitus+Model+Rats&rft.jtitle=Hypertension+Research&rft.au=SHINOMIYA%2C+Kaori&rft.au=FUKUNAGA%2C+Megumu&rft.au=KIYOMOTO%2C+Hideyasu&rft.au=MIZUSHIGE%2C+Katsufumi&rft.date=2002&rft.pub=The+Japanese+Society+of+Hypertension&rft.issn=0916-9636&rft.eissn=1348-4214&rft.volume=25&rft.issue=1&rft.spage=91&rft.epage=98&rft_id=info:doi/10.1291%2Fhypres.25.91&rft.externalDocID=article_hypres_25_1_25_1_91_article_char_en
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0916-9636&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0916-9636&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0916-9636&client=summon